Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “breast cancer”

Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid TumorsActive Not Recruiting
NCT03915678Phase 2Updated Jul 24, 2026
Sponsor: Institut Bergonié
Solid Tumor, Adult · Pancreatic Cancer · Virus-associated Tumors · Non Small Cell Lung Cancer
France
WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer TreatmentRecruiting
NCT06291324N/AUpdated Jul 24, 2026
Sponsor: Wake Forest University Health Sciences
Pancreatic Cancer · Breast Cancer
United States
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast CancerRecruiting
NCT05412225Phase 1Updated Jul 24, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Breast Cancer · Invasive Breast Cancer
United States
Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian CancerRecruiting
NCT06856499Phase 1Updated Jul 24, 2026
Sponsor: University of Colorado, Denver
Endometrioid Ovarian Cancer · Primary Peritoneal Cancer · Fallopian Tube Cancer
United States
SMP-656 for HER2-Positive Advanced Breast CancerNot Yet Recruiting
NCT07726342Phase 2Updated Jul 24, 2026
Sponsor: Chengdu SciMount Pharmatech Co., Ltd.
HER2-positive Breast Cancer · Metastatic Breast Cancer · Locally Advanced Breast Cancer (LABC)
China
Outcomes and Cosmesis With Whole Breast Irradiation and BoostActive Not Recruiting
NCT06295744NAUpdated Jul 24, 2026
Sponsor: University of Wisconsin, Madison
Early-stage Breast Cancer
United States
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.Active Not Recruiting
NCT06247995Phase 1, Phase 2Updated Jul 24, 2026
Sponsor: Novartis Pharmaceuticals
Breast Cancer
United States, Australia, Canada, China, France +6 more
To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.Recruiting
NCT06970275N/AUpdated Jul 24, 2026
Sponsor: XEOS Medical
Prostate Cancers · Breast Cancer · Head and Neck Cancer · Cancer
Belgium, Germany, Netherlands, United Kingdom
Evaluating the Impact of Digital Behavioral Interventions to Address Insomnia and Depression in Breast Cancer Survivors Using an Adaptive DesignNot Yet Recruiting
NCT07721064NAUpdated Jul 24, 2026
Sponsor: University of Virginia
Insomnia · Depression
United States
Tomosynthesis as Primary Test for Breast Cancer ScreeningActive Not Recruiting
NCT04461808NAUpdated Jul 24, 2026
Sponsor: Azienda USL Reggio Emilia - IRCCS
Breast Cancer
Italy
IDOV-Immune for Advanced Solid TumorsRecruiting
NCT06910657Phase 1Updated Jul 24, 2026
Sponsor: ViroMissile, Inc.
Colorectal Cancer · Pancreatic Cancer · Melanoma · Ovarian Cancer
United States, Australia
Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.Active Not Recruiting
NCT04053322Phase 2Updated Jul 24, 2026
Sponsor: UNICANCER
ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer · a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
France
Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal WomenCompleted
NCT06315205Phase 1Updated Jul 24, 2026
Sponsor: Rovi Pharmaceuticals Laboratories
Healthy
Czechia
Researching the Effect of Exercise on CancerActive Not Recruiting
NCT04589468NAUpdated Jul 24, 2026
Sponsor: City of Hope Medical Center
Breast Cancer · Prostate Cancer · Colorectal Cancer · Stage I Breast Cancer
United States
Impact of Pilates Exercises on Bone Mineral Density in Breast Cancer Survivors Receiving Hormonal TherapyCompleted
NCT07334626NAUpdated Jul 24, 2026
Sponsor: Benha University
Breast Cancer · Breast Cancer Survivors · Aromatase Inhibitors · Osteoporosis or Osteopenia
Egypt
Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast CancerRecruiting
NCT06606730Phase 3Updated Jul 23, 2026
Sponsor: UNICANCER
Breast Cancers · Triple Negative Breast Cancer (TNBC)
Belgium, France
IORT-Breast at Medical Center Navicent HealthActive Not Recruiting
NCT04595435N/AUpdated Jul 23, 2026
Sponsor: Wake Forest University Health Sciences
Breast Cancer Female · Early-stage Breast Cancer
United States
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)Recruiting
NCT07060807Phase 3Updated Jul 23, 2026
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms
United States, Argentina, Australia, Brazil, Canada +21 more
Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C TrialNot Yet Recruiting
NCT07723235NAUpdated Jul 23, 2026
Sponsor: Ohio State University Comprehensive Cancer Center
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · Endometrial Carcinoma
United States
Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing Breast-Conserving SurgeryNot Yet Recruiting
NCT07723469Phase 3Updated Jul 23, 2026
Sponsor: SURGE Therapeutics
TNBC - Triple-Negative Breast Cancer
United States
Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast CancerRecruiting
NCT05874297NAUpdated Jul 23, 2026
Sponsor: Fred Hutchinson Cancer Center
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8
United States
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02)Active Not Recruiting
NCT06382142Phase 3Updated Jul 23, 2026
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Triple-Negative Breast Cancer
China
Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME)Recruiting
NCT07491380NAUpdated Jul 23, 2026
Sponsor: Institut Curie
Breast Cancer
France
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up StudyCompleted
NCT00006421N/AUpdated Jul 23, 2026
Sponsor: National Cancer Institute (NCI)
Breast Cancer
United States
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid TumorsRecruiting
NCT06618287Phase 1, Phase 2Updated Jul 23, 2026
Sponsor: Bristol-Myers Squibb
Lung Cancer · Breast Cancer
United States, Australia, Canada, Chile, France +4 more

Previous page Next page